-transparent.png){kind=logo}
In a study of nonsteroidal antiinflammatory and analgesic agents, a series of 1,3-dihydro-3-(substituted phenyl)imidazo[4,5-b]pyridin-2-ones-and 3-(substituted phenyl)triazolo[4,5-b]pyridines was prepared. Many of the imidazolones were alkylated on the free nitrogen. In a modified Randall-Selitto analgesic assay, the pain thresholds of both the inflamed and normal foot were elevated. This is not commonly observed with nonsteroidal antiinflammatory agents. The most active compounds were 1,3-dihydro-3[3,4-(methylenedioxy)phenyl]imidazo[4,5-b]pyridin-2-one (I-15) and its N-allyl (I-21) and N-isopropyl (I-121) derivatives. In the triazole series the 3-(2-fluoro- and 2,4-difluorophenyl)triazolo[4,5-b]pyridines (T-1 and T-8) were the best. The imidazole compounds were somewhat superior in analgesic activity to codeine and d-propoxyphene without showing any narcotic characteristics. Some of the compounds also possessed activity against carrageenan-induced foot edema in the rat, so these compounds represent a new class of nonnarcotic analgesic antiinflammatories, capable of producing a greater degree of analgesia than that obtainable with other nonsteroidal antiinflammatory agents.
R L Clark, and
A A Pessolano, and
T Y Shen, and
D P Jacobus, and
H Jones, and
V J Lotti, and
L M Flataker
October 2004,
The Journal of organic chemistry,
R L Clark, and
A A Pessolano, and
T Y Shen, and
D P Jacobus, and
H Jones, and
V J Lotti, and
L M Flataker
May 1973,
Journal of medicinal chemistry,
R L Clark, and
A A Pessolano, and
T Y Shen, and
D P Jacobus, and
H Jones, and
V J Lotti, and
L M Flataker
January 2008,
Journal of combinatorial chemistry,
R L Clark, and
A A Pessolano, and
T Y Shen, and
D P Jacobus, and
H Jones, and
V J Lotti, and
L M Flataker
April 2016,
The Journal of organic chemistry,
R L Clark, and
A A Pessolano, and
T Y Shen, and
D P Jacobus, and
H Jones, and
V J Lotti, and
L M Flataker
May 2011,
Acta crystallographica. Section E, Structure reports online,
R L Clark, and
A A Pessolano, and
T Y Shen, and
D P Jacobus, and
H Jones, and
V J Lotti, and
L M Flataker
December 2022,
Molecules (Basel, Switzerland),
R L Clark, and
A A Pessolano, and
T Y Shen, and
D P Jacobus, and
H Jones, and
V J Lotti, and
L M Flataker
March 2007,
Beilstein journal of organic chemistry,
R L Clark, and
A A Pessolano, and
T Y Shen, and
D P Jacobus, and
H Jones, and
V J Lotti, and
L M Flataker
November 1976,
The Journal of organic chemistry,
R L Clark, and
A A Pessolano, and
T Y Shen, and
D P Jacobus, and
H Jones, and
V J Lotti, and
L M Flataker
May 2013,
Organic & biomolecular chemistry,
R L Clark, and
A A Pessolano, and
T Y Shen, and
D P Jacobus, and
H Jones, and
V J Lotti, and
L M Flataker
December 1998,
Anti-cancer drug design,
